Schrodinger Inc (SDGR) Biznesning o‘zini qoplash muddati

Schrödinger Inc. - SDGR emitenti grafik logotipi

Schrodinger, Inc. uzoq davom etadigan testlarni hisob-kitoblar bilan almashtirish orqali dori vositalarini kashf qilishni tezlashtiruvchi hisoblash dasturiy ta'minotini ishlab chiqadi. GURU.Markets platformasida kompaniyaning P/E ko'rsatkichlari tebranishlari kapital baholash dinamikasini aks ettiradi, bunda ko'rsatkich darajasi -33.50 ni tashkil etadi. Molekulyar modellashtirish uchun majburiy litsenziyalar barqaror daromad oqimini ta'minlaydi. Tadqiqot va ishlanmalar (R&D) jarayonlarida dasturiy ta'minotni almashtirishning yuqori murakkabligi bozor himoyasini mustahkamlaydi va obuna asosidagi daromadlarni kafolatlaydi.

P/E multiplikatori: schrodinger.com (SDGR) 04.07.2022 - 14.11.2026 uchun

Schrodinger, Inc. kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Kompaniyaning jamlanma tahlili:schrodinger.com SDGR
Schrödinger yetakchi tovari

Schrodinger (SDGR) IT platformasining litsenziyalar va startaplardagi ulushlar orqali monetizatsiyasi biznesni kelgusidagi kashfiyotlarga bog'liq qiladi, bu esa bozor kapitalizatsiyasining haqiqiy daromadlar bilan qat'iy muvofiqligini taqozo etadi. Kompaniyaning joriy P/E koeffitsiyenti tahlili texnologik yetakchilik uchun to'langan premiumni aniqlash imkonini beradi, bu esa investorlarga kirish nuqtalarini belgilashda fundamental past baholanganlikni "qiymat tuzog'i"dan ajratishga yordam beradi.

Muhim raqobatchilar

Narx-foyda multiplikatori VEEV (veeva.com)|Narxning foydaga nisbati Doximity (DOCS)|Biznesning o‘zini qoplash muddati HealthEquity Inc|P/E multiplikatori WAY (Waystar Inc.)|CRVL - Narx-foyda koeffitsiyenti|Privia Health Group - P/E multiplikatori|Kompaniya qiymatining sof foydaga nisbati HURN (huronconsultinggroup.com)|Certara (CERT) - Narxning foydaga nisbati|Omnicell Inc - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati GoodRx Corp|Kapitalizatsiyaning foydaga nisbati Phreesia Health PHR|P/E multiplikatori OMDA|evolenthealth.com - Narx-foyda multiplikatori|P/E multiplikatori HSTM (HealthStream)|Biznesning o‘zini qoplash muddati Definitive Healthcare Corp (DH)|CCSI - Narxning foydaga nisbati|AGL (Agilon Health Corp) - Narx-foyda multiplikatori|ABSI: P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti soyoung.com SY|NRC (National Research Corporation) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Spok Holdings Inc SPOK|Narxning foydaga nisbati OptimizeRx Corp. (OPRX)|TBRG (TruBridge Corp) - Kompaniya qiymatining sof foydaga nisbati|Simulations Plus, Inc. - Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati SOPH|Health Catalyst - P/E multiplikatori|Biznesning o‘zini qoplash muddati CareCloud, Inc. CCLD|Research Solutions, Inc. (RSSS) - Narxning foydaga nisbati|Narx-foyda multiplikatori DLHC|ONMD (OneMedNet Corp) - P/E multiplikatori|Narx-foyda koeffitsiyenti scienture.com (SCNX)|Narx-foyda koeffitsiyenti HCTI (Healthcare Triangle, Inc.)|Biznesning o‘zini qoplash muddati ispecimen.com|Narxning foydaga nisbati Bullfrog AI BFRG|Biznesning o‘zini qoplash muddati SCWorx Inc (WORX)|MSP Recovery Inc - P/E multiplikatori|ICCT (iCoreConnect Inc.) - Narx-foyda multiplikatori|MEDS: P/E multiplikatori|Kapitalizatsiyaning sof foydaga nisbati koeffitsiyenti Orgenesis Inc ORGS|Narxning foydaga nisbati R1 RCM, Inc.|SHCR: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori STRM|Biznesning o‘zini qoplash muddati syrahealth.com|Apollo Medical Holdings, Inc. - Narx-foyda koeffitsiyenti|Bozor narxining sof foydaga nisbati MODN (Model N Inc)|NXGN: Narx-foyda koeffitsiyenti